This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Hang on a second…

This CME Activity has expired and is no longer available for credit.

2018 Virtual Symposium: Updates in Inflammation and Secondary CVD Prevention

2018 Virtual Symposium: Updates in Inflammation and Secondary CVD Prevention

Format

Webcast

Time to Complete

1 hour

Released

July 13, 2018

Expires

July 13, 2019
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM
1.00 / CNE for Nurses (0.30 pharmacotherapy hours)
1.00 / CE for Pharmacists (0.10 CEUs)
1.00 / CPEU for Registered Dietitians

Accredited Provider

This activity is jointly provided by Global Education Group and Tarsus Cardio Inc. dba Cardiometabolic Health Congress.

Commercial Supporter

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Program Description

During this activity, Brendan M. Everett, MD, and Ishwarlal Jialal, MD, PhD, will provide an overview of the role of inflammation in the pathogenesis of atherosclerosis and atherothrombotic events and residual inflammatory risks in patients with CVD. The expert faculty will focus on the role of biomarkers in assessing secondary CVD risk and review the most recent clinical trial data from the completed CANTOS study and the ongoing CIRT trial. The activity will conclude with an interactive patient case moderated by Christie M. Ballantyne, MD, to demonstrate a patient at risk for secondary CVD and how managing inflammation may potentially reduce that risk. Participants will also be given the opportunity to pose questions and interact with the expert faculty during this time to enhance their knowledge and clinical practice.

Intended Audience

US-based healthcare professionals, including primary care clinicians (PCPs), nurse practitioners (NPs), physician assistants (PAs), endocrinologists, diabetologists, pharmacists, cardiologists, lipidologists, and other allied health professionals

Educational Objectives

Upon completion of this activity, participants should be able to:

  • Explain the role of inflammation in the underlying pathogenesis of the development and progression of atherosclerosis
  • Identify the role of inflammatory biomarkers in the assessment of secondary CVD risk
  • Review the results from clinical trials for emerging non-statin therapies targeting inflammation for the secondary prevention of CVD

Conflict Of Interest Disclosure Policy

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty

Christie M. Ballantyne, MD (Chair)
Professor of Medicine
Chief, Section of Cardiovascular Research
Chief, Section of Cardiology
Department of Medicine, Baylor College of Medicine
Director, Center for Cardiovascular Disease Prevention
Baylor College of Medicine
Methodist DeBakey Heart Center
Houston, TX

Dr. Ballantyne discloses the following:
Grant/Research Support (all significant, all paid to institution, not individual): Abbott Diagnostic, Amarin, Amgen, Esperion, lonis, Novartis, Pfizer, Regeneron, Roche Diagnostic, Sanofi Synthelabo, NIH, AHA, ADA
Consultant/Independent Contractor: Abbott Diagnostics, Amarin, Amgen, AstraZeneca*, Boehringer lngelheim*, Eli Lilly, Esperion, lonis, Matinas BioPharma Inc, Merck*, Novartis, Pfizer*, Regeneron, Roche Diagnostic, Sanofi-Synthelabo*
*Significant where noted (>$10,000); remainder modest (<$10,000)

Brendan M. Everett, MD
Assistant Professor, HMS
Director, Impatient General Cardiology
Brigham and Women’s Hospital
Boston, MA

Dr. Everett discloses the following:
Consultant/Independent Contractor: Roche Diagnostic
Grant/Research Support: Novartis – Grant to BWH

Ishwarlal Jialal, MD, PhD
Assistant Dean of Research
Professor of Physiology, Metabolism and Pathology
California Northstate University - College of Medicine
Elk Grove, CA

Dr. Jialal has nothing to disclose.

Accredited Provider Disclosure

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Ashley Marostica, RN, MSN, has nothing to disclose.
Lindsay Borvansky has nothing to disclose.
Andrea Funk has nothing to disclose.
Amanda Turner has nothing to disclose.
Erin Franceschini, MS, has nothing to disclose.
Amanda Jamrogiewicz has nothing to disclose.
Karin McAdams has nothing to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and CMHC. Global is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

Global Education Group designates this virtual activity for a maximum of 1.00 AMA PRA Category 1 CreditTM  . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Credit

1.00

Type

CNE Contact Hour(s)

Accreditation Statement

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Designation Statement

This educational activity for 1.00 contact hour is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

This activity includes 0.30 pharmacotherapy hour.

Credit

1.00

Type

CE for Pharmacists

Accreditation Statement

Global Education Group is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Designation Statement

Global Education Group designates this continuing education activity for 1.00 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. This is a knowledge based activity.

Universal Activity Number (UAN): 0530-9999-18-196-H01-P

Credit

1.00

Type

CPEU Credit

Accreditation Statement

Global Education Group is a Continuing Professional Education (CPE) Accredited Provider with the Commission on Dietetic Registration (CDR).

Designation Statement

CDR Credentialed Practitioners will receive 1.00 Continuing Professional Education units (CPEUs) for completion of this activities / materials.

CPE Provider #GE012

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) and CMHC do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Instructions

To obtain credit, a score of 70% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.

For information about the accreditation of this activity, please contact Global Education Group at 303-395-1782 or cme@globaleducationgroup.com.

If you have any other questions relating to your certificate or other issues with the activity, please contact myCME.Support@haymarketmedical.com.

Privacy Policy

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue